Literature DB >> 2078421

Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications.

J Ongradi1, L Ceccherini-Nelli, M Pistello, S Specter, M Bendinelli.   

Abstract

Infectivity of free and cell-associated human immunodeficiency virus type 1 (HIV-1) treated in vitro at pH 7.4 to 4.9 for 2 hours was assessed on susceptible CEM-ss cells. Viral activity was monitored by cytopathology and production of reverse transcriptase and p24 antigen. The infectivity of cell-free virus was gradually inactivated and at pH 5.4 was completely lost, with or without subsequent adjustment of pH to neutral. Virus-producing cells also gradually lost their ability to infect as the pH decreased; however, restoration of neutral pH resulted in regained infectivity. Since the pH values used in the study are similar to those found at various entry sites of the human body, the data may be relevant to the mode of transmittal of HIV.

Entities:  

Mesh:

Year:  1990        PMID: 2078421     DOI: 10.1089/aid.1990.6.1433

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.

Authors:  Xin Qiao; Jaekyun Jeon; Amy L Cole; Jason O Matos; Stephany Bautista; Justin Castillo; Ivan Hung; Zhehong Gan; Suren A Tatulian; Alexander M Cole; Bo Chen
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

Review 2.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

3.  Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.

Authors:  J Ongrádi; H M Laird; J F Szilágyi; A Horváth; M Bendinelli
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

4.  The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.

Authors:  Jacklyn Johnson; Manuel G Flores; John Rosa; Changze Han; Alicia M Salvi; Kris A DeMali; Jennifer R Jagnow; Amy Sparks; Hillel Haim
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

5.  In vivo semen-associated pH neutralization of cervicovaginal secretions.

Authors:  C Tevi-Bénissan; L Bélec; M Lévy; V Schneider-Fauveau; A Si Mohamed; M C Hallouin; M Matta; G Grésenguet
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

6.  A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women.

Authors:  L Van Damme; A Wright; K Depraetere; I Rosenstein; V Vandersmissen; L Poulter; M McKinlay; E Van Dyck; J Weber; A Profy; M Laga; V Kitchen
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

Review 7.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

Review 8.  HIV-1 assembly in macrophages.

Authors:  Philippe Benaroch; Elisabeth Billard; Raphaël Gaudin; Michael Schindler; Mabel Jouve
Journal:  Retrovirology       Date:  2010-04-07       Impact factor: 4.602

9.  Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia.

Authors:  C J Miller; M Marthas; J Torten; N J Alexander; J P Moore; G F Doncel; A G Hendrickx
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

Review 10.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.